How to manage dysphasia in a patient taking Lyrica (pregabalin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Dysphagia in Patients Taking Pregabalin (Lyrica)

Pregabalin should be discontinued or dose-reduced in patients experiencing dysphagia, as it may be a medication-induced adverse effect, while implementing appropriate dysphagia management strategies based on individual assessment.

Understanding the Relationship Between Pregabalin and Dysphagia

Pregabalin (Lyrica) is an anticonvulsant medication that acts on calcium channels through binding to alpha2-delta subunits, reducing the release of several neurotransmitters 1. While primarily used for neuropathic pain, epilepsy, and anxiety disorders, pregabalin can cause neurological adverse effects that may affect swallowing function.

Potential Mechanisms of Pregabalin-Induced Dysphagia:

  1. Neurological effects: Pregabalin can cause central nervous system depression, dizziness, and somnolence 2, which may impair coordination of swallowing muscles
  2. Myoclonic activity: Case reports have documented pregabalin-associated myoclonus and encephalopathy 3, 4, which could potentially affect oropharyngeal muscle control
  3. Sedative effects: The sedative properties of pregabalin may reduce alertness and coordination needed for safe swallowing

Management Algorithm for Pregabalin-Associated Dysphagia

Step 1: Assess and Confirm Dysphagia

  • Perform dysphagia screening using a validated tool 5
  • Refer to Speech-Language Pathologist (SLP) for comprehensive assessment of swallowing function 5
  • Determine severity and characteristics of dysphagia through clinical and instrumental assessment

Step 2: Medication Management

  • Consider discontinuation or dose reduction of pregabalin
    • If dysphagia onset correlates with pregabalin initiation or dose increase
    • Monitor for improvement in swallowing function after medication adjustment
  • Consider alternative medications for the original indication:
    • For neuropathic pain: tricyclic antidepressants or SNRIs (particularly duloxetine) 5
    • For seizure control: consult neurology for alternative anticonvulsants
    • For anxiety: SSRIs or SNRIs 2

Step 3: Implement Dysphagia Management Strategies

  • Modify food and fluid consistency according to individual assessment results 5

    • Thickened liquids may reduce aspiration risk in appropriate patients
    • Pudding-thick consistency may be safer but increases oral transit time 5
  • Implement rehabilitation techniques:

    • Chin tuck against resistance exercises 5
    • Respiratory muscle strength training for patients without tracheostomy 5
    • Postural adjustments during swallowing 5
    • Swallowing maneuvers based on specific physiologic deficits 5
  • Consider nutritional support:

    • Maintain hydration with appropriate fluid consistency
    • Ensure adequate nutrition through modified diet
    • If oral intake remains unsafe, consider nasogastric tube or PEG placement 5

Monitoring and Follow-up

  • Regular reassessment of swallowing function by SLP
  • Monitor for signs of aspiration pneumonia, malnutrition, or dehydration 5
  • Adjust management plan based on patient response
  • Provide education to patient and caregivers about safe swallowing techniques 5

Special Considerations

  • Patients with renal impairment: Pregabalin is primarily excreted unchanged by the kidneys. Patients with renal dysfunction may experience more severe adverse effects due to drug accumulation, even without elevated plasma levels 4

  • Elderly patients: Higher sensitivity to CNS effects of pregabalin; consider lower starting doses and more gradual titration

  • Patients with comorbid neurological conditions: Underlying neurological disorders may exacerbate pregabalin-related dysphagia; careful monitoring is essential

Pitfalls to Avoid

  1. Assuming dysphagia is solely due to stroke or other neurological conditions without considering medication effects
  2. Continuing pregabalin at the same dose despite temporal relationship with dysphagia onset
  3. Relying solely on compensatory strategies without addressing the potential medication cause
  4. Inadequate monitoring of nutritional status and hydration during dysphagia management
  5. Failing to involve a multidisciplinary team including SLP, physician, pharmacist, and dietician

By following this structured approach to managing pregabalin-associated dysphagia, clinicians can improve patient outcomes while addressing both the underlying cause and functional impairment of swallowing.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.